Discover 2,226 paid clinical trials in San Francisco, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
San Francisco offers opportunities for individuals interested in taking part in paid studies as healthy volunteers, as well as those looking for studies for a specific medical condition. The city has a strong emphasis on cutting-edge research for conditions such as HIV/AIDS, oncology, kidney disease, PCOS, and endometriosis, among others. By participating, you can gain access to the latest healthcare innovations and contribute to pioneering medical progress.
Filter
2
Filter results
Results: 2,226
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
for
Breast Carcinoma, Colorectal Carcinoma,
Location: San Francisco CA, South San Francisco CA, Oakland CA,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT06418204
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Location: San Francisco CA, South San Francisco CA, Oakland CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04181060
Phase3, Recruiting
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
for
Aortic Valve Insufficiency, Aortic Valve Stenosis
Location: San Francisco CA, Stanford CA, Newport Beach CA,
Sponsor: Edwards Lifesciences
Sex: All
Age: 0+
Code: NCT05172973
Recruiting
Examining a Novel Gastrointestinal Intervention to Negate Environmental Toxicants (ENGINE)
for
Toxicant Exposure, Firefighter,
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: Male
Age: 18+
Code: NCT07226440
Phase1, Phase2, Recruiting
Investigating the Use of Intravenous Tranexamic Acid in Gender Affirming Mastectomy
for
Postoperative Hematoma, Postoperative Seroma
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: Female
Age: 18+
Code: NCT05794321
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Ph1 Lobeline Interaction Study - 1
for
Methamphetamine Dependence
Location: San Francisco CA
Sponsor: National Institute on Drug Abuse (NIDA)
Sex: Female
Age: 18 - 45
Code: NCT00439504
Phase1, Recruiting
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: San Francisco CA, Stanford CA, Sacramento CA,
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All
Age: 0+
Code: NCT01351545
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
for
Urothelial Carcinoma
Location: San Francisco CA, Templeton CA, San Luis Obispo CA,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT04879329
Phase2, Recruiting
MTX-001 for the Treatment of Non-Healing Venous Stasis Ulcers
for
Venous Stasis Ulcer, Venous Leg Ulcer
Location: San Francisco CA, Castro Valley CA, Tucson AZ,
Sponsor: Merakris Therapeutics
Sex: All
Age: 18+
Code: NCT04647240
Phase2, Recruiting
New
The Impact of Dietary Salt on the Severity of Eczema
for
Eczema, Atopic Dermatitis
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 18+
Code: NCT07447063
Recruiting
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
for
Pancreatic Neoplasm
Location: San Francisco CA, Sacramento CA, Burbank CA,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 50 - 70+
Code: NCT04239573
Recruiting
Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity
for
Chronic Pain
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 18+
Code: NCT06183281
Recruiting
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations